{"organizations": ["Cerus", "Morgan Stanley Global Healthcare Unplugged Conference", "Cerus Corporation"], "uuid": "85395c35e40e6798528b59afb605bc764b2e3b8d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "finance.yahoo.com", "main_image": "http://l3.yimg.com/bt/api/res/1.2/M7vS95b2fvSzHFeFStPk0A--/YXBwaWQ9eW5ld3NfbGVnbztxPTc1O3c9NjAw/http://l.yimg.com/os/mit/media/m/social/images/social_default_logo-1481777.png", "site_section": "http://finance.yahoo.com/rss/Biotechnology", "section_title": "Yahoo! Finance: Biotechnology Industry News", "url": "http://finance.yahoo.com/news/cerus-present-morgan-stanley-global-123000855.html", "country": "GB", "title": "Cerus to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 17, 2015", "performance_score": 0, "site": "yahoo.com", "participants_count": 0, "title_full": "Cerus to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 17, 2015", "spam_score": 0.0, "site_type": "news", "published": "2015-09-10T15:30:00.000+03:00", "replies_count": 0, "uuid": "85395c35e40e6798528b59afb605bc764b2e3b8d"}, "author": "", "url": "http://finance.yahoo.com/news/cerus-present-morgan-stanley-global-123000855.html", "ord_in_thread": 0, "title": "Cerus to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 17, 2015", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Cerus to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 17, 2015 Cerus Corporation 8 minutes ago  Done \nCONCORD, Calif.--(BUSINESS WIRE)-- \nCerus Corporation ( CERS ) announced today that William “Obi” Greenman, Cerus’ president and chief executive officer, is scheduled to present a corporate update at the Morgan Stanley Healthcare Unplugged Conference at 8:00 AM ET on Thursday, September 17, 2015. \nA live webcast of the presentation will be available from the Investor Relations page of the Cerus web site at http://www.cerus.com/ir . A replay will be available for approximately two weeks following the completion of the event. \nABOUT CERUS \nCerus Corporation is a biomedical products company focused in the field of blood safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in donated blood. The nucleic acid targeting mechanism of action of the INTERCEPT treatment is designed to inactivate established transfusion threats, such as hepatitis B and C, HIV, West Nile virus and bacteria, as well as emerging pathogens such as Chikungunya, malaria and dengue. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in the United States, Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. The INTERCEPT red blood cell system is in clinical development. See http://www.cerus.com for information about Cerus. \nINTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation. View source version on businesswire.com: http://www.businesswire.com/news/home/20150910005005/en/ Contact:", "external_links": [], "published": "2015-09-10T15:30:00.000+03:00", "crawled": "2015-09-10T15:39:28.639+03:00", "highlightTitle": ""}